NUTEX HEALTH INC (NUTX) Stock Income Statement
NASDAQ:NUTX - Nasdaq - US67079U3068 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 624.28M | 479.95M | 247.65M | 219.29M | 18.79M | |||
| Minority Interest Expense | -72.86M | -43.09M | -2.36M | 7.96M | -1.00K | |||
| Cost Of Goods | 319.84M | 283.69M | 212.87M | 205.84M | 14.65M | |||
| Gross Profit | 304.44M | 196.26M | 34.77M | 13.45M | 4.15M | |||
| Operating Expenses | 95.98M | 58.56M | 36.07M | 18.03M | 13.16M | |||
| Research and Development | N/A | N/A | N/A | N/A | 286.00K | |||
| Selling, General, and Administrative Expenses | 95.98M | 58.56M | 36.07M | 18.03M | 12.20M | |||
| Operating Income | 208.46M | 137.71M | -1.29M | -4.58M | -9.02M | |||
| Interest Income/Expense | -21.61M | -19.93M | -16.32M | -12.49M | -6.27M | |||
| Other Income/Expense | -7.11M | -940.00K | -399.00K | -559.00K | N/A | |||
| Non Recurring Items | N/A | -7.08M | -30.48M | -402.02M | 637.00K | |||
| Income Before Taxes | 172.67M | 109.75M | -48.49M | -419.65M | -14.65M | |||
| Income Tax | 32.63M | 14.48M | -5.07M | 13.09M | -985.00K | |||
| Net Income | 67.18M | 52.18M | -45.79M | -424.78M | -13.67M | |||
| EBITDA | 228.34M | 156.68M | 16.30M | 8.55M | -8.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 10.09 | 9.71 | -1.04 | -10.04 | -5.49 | |||
| Non GAAP EPS | 11.89 | 8.73 | -4.50 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 48.77% | 40.89% | 14.04% | 6.13% | 22.07% | |||
| Profit Margin | 10.76% | 10.87% | -18.49% | -193.70% | -72.74% | |||
| Operating Profit Margin | 33.39% | 28.69% | -0.52% | -2.09% | -47.98% | |||
All data in USD